2021
Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With COVID-19
Cha S, Henry A, Montgomery M, Laws R, Pham H, Wortham J, Garg S, Kim L, Mosites E, Chai S, Kawasaki B, Meek J, Anderson E, Weigel A, Ryan P, Kim S, Como-Sabetti K, Torres S, Muse A, Bennett N, Billing L, Sutton M, Talbot H, Risk I. Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With COVID-19. The Journal Of Infectious Diseases 2021, 224: 425-430. PMID: 33993309, PMCID: PMC8194564, DOI: 10.1093/infdis/jiab261.Peer-Reviewed Original ResearchConceptsMechanical ventilationCOVID-19-associated hospitalizationNon-Hispanic black personsCOVID-19Population-based surveillance dataHealth conditionsChronic health conditionsCoronavirus disease 2019ICU admissionClinical characteristicsRespiratory supportClinical outcomesSevere illnessDisease 2019High riskSurveillance dataAdults Experiencing HomelessnessAnalytic sampleEthnic minority groupsHousing statusBlack personsVentilationDeathOutcomesHospitalization
2015
Burden of Clostridium difficile Infection in the United States
Lessa F, Mu Y, Bamberg W, Beldavs Z, Dumyati G, Dunn J, Farley M, Holzbauer S, Meek J, Phipps E, Wilson L, Winston L, Cohen J, Limbago B, Fridkin S, Gerding D, McDonald L. Burden of Clostridium difficile Infection in the United States. New England Journal Of Medicine 2015, 372: 825-834. PMID: 25714160, PMCID: PMC10966662, DOI: 10.1056/nejmoa1408913.Peer-Reviewed Original ResearchConceptsClostridium difficile infectionDifficile infectionFirst recurrenceHealth care-associated infectionsCommunity-associated infectionsC. difficile infectionCare-associated infectionsPersons 65 yearsLaboratory-based surveillanceType 1 strainsNumber of deathsNational incidenceMolecular typingC. difficileInfectionIncidenceDeathUnited StatesRecurrenceGeographic areasSample of casesEstimated numberRegression modelsActive populationHealthStatin Treatment and Mortality: Propensity Score-Matched Analyses of 2007–2008 and 2009–2010 Laboratory-Confirmed Influenza Hospitalizations
Laidler M, Thomas A, Baumbach J, Kirley P, Meek J, Aragon D, Morin C, Ryan P, Schaffner W, Zansky S, Chaves S. Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007–2008 and 2009–2010 Laboratory-Confirmed Influenza Hospitalizations. Open Forum Infectious Diseases 2015, 2: ofv028. PMID: 26034777, PMCID: PMC4438907, DOI: 10.1093/ofid/ofv028.Peer-Reviewed Original ResearchPropensity score-matched analysisStatin treatmentAdjunct treatmentInfluenza virus infectionHost inflammatory responseAnnual influenza epidemicsInfluenza hospitalizationsInfluenza seasonSubstantial morbidityHospitalized cohortCox regressionImmunomodulatory agentsInflammatory responseVirus infectionProtective effectInfluenza epidemicsSurveillance dataMortalityUnmeasured confoundersStatinsDeathTreatmentVaccine productionInfluenzaPandemic
2008
The mortality burden of chronic liver disease may be substantially underestimated in the United States.
Durante AJ, St Louis T, Meek JI, Navarro VJ, Sofair AN. The mortality burden of chronic liver disease may be substantially underestimated in the United States. Connecticut Medicine 2008, 72: 389-92. PMID: 18763665.Peer-Reviewed Original ResearchConceptsChronic liver diseaseICD-10 codesLiver diseaseEnd-stage liver diseaseStage liver diseaseDeath certificate dataCause of deathMedical examiner recordsCLD burdenCLD statusMedical chartsMortality burdenDeath certificatesCertificate dataHealth StatisticsCounty residentsDiseaseGold standardBurdenSerious diseaseDeathUnited States National CenterDetrimental effectsSpecificityPreventionUnexplained Deaths in Connecticut, 2002–2003:Failure to Consider Category A Bioterrorism Agents in Differential Diagnoses
Palumbo JP, Meek JI, Fazio DM, Turner SB, Hadler JL, Sofair AN. Unexplained Deaths in Connecticut, 2002–2003:Failure to Consider Category A Bioterrorism Agents in Differential Diagnoses. Disaster Medicine And Public Health Preparedness 2008, 2: 87-94. PMID: 18525371, DOI: 10.1097/dmp.0b013e318161315b.Peer-Reviewed Original ResearchConceptsInfectious deathUnexplained deathDifferential diagnosisConnecticut death certificatesInitial casesEmergency department cliniciansBioterrorism agentsCategory A Bioterrorism AgentsClinical presentationClinician educationDeath certificatesDiagnostic testingSurveillance strategiesConnecticut physiciansFirst lineDeathChart informationDiagnosisTularemiaBioterrorism attackBioterrorist attackSmallpoxAnthraxBotulismSerology
2001
Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut.
Kluger M, Sofair A, Heye C, Meek J, Sodhi R, Hadler J. Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut. American Journal Of Public Health 2001, 91: 1214-9. PMID: 11499106, PMCID: PMC1446748, DOI: 10.2105/ajph.91.8.1214.Peer-Reviewed Original ResearchConceptsActive prospective surveillanceInfectious causesUnexplained illnessProspective surveillanceRetrospective surveillanceRetrospective validationProspective surveillance systemHospital discharge dataSurveillance systemSuch patientsAnnual incidenceStudy criteriaMedical recordsNew Haven CountyComputerized searchIllnessLess labor-intensive alternativeDeathLabor-intensive alternativePatientsReference populationSurveillanceCauseDischarge dataStudy counties